Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A TEICHER

Showing results (41-50 of 372) with videos related to

Pageof 38
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
CXCL12 (SDF-1)/CXCR4 pathway in cancerBeverly A Teicher, Simon P Fricker
Journal of Medicinal Chemistry|August 1, 1980
Nitrobenzyl halides and carbamates as prototype bioreductive alkylating agentsB A Teicher, A C Sartorelli
Anticancer Research|November 1, 1996
Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cellsG Chen, B A Teicher, E Frei
Cancer Chemotherapy and Pharmacology|October 29, 2000
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agentsK Lu, C Shih, B A Teicher
The Lancet. Oncology|June 15, 2016
Antibody-drug conjugates for cancer therapyAnish Thomas, Beverly A Teicher, Raffit Hassan
Lung Cancer Management|October 25, 2019
Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?Dmitriy Sonkin, Anish Thomas, Beverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody conjugate therapeutics: challenges and potentialBeverly A Teicher, Ravi V J Chari
Cancer Biochemistry Biophysics|January 29, 1999
Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotypeG Chen, B A Teicher, E Frei
Cancer Genetics|June 23, 2024
Cancer treatments: Past, present, and futureDmitriy Sonkin, Anish Thomas, Beverly A Teicher
Archives of Internal Medicine|December 1, 1978
Minoxidil-induced bullous eruptionT Rosenthal, A Teicher, J Swartz, et al.
Pageof 38

Showing results (41-50 of 372) with videos related to

Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
CXCL12 (SDF-1)/CXCR4 pathway in cancerBeverly A Teicher, Simon P Fricker
Journal of Medicinal Chemistry|August 1, 1980
Nitrobenzyl halides and carbamates as prototype bioreductive alkylating agentsB A Teicher, A C Sartorelli
Anticancer Research|November 1, 1996
Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cellsG Chen, B A Teicher, E Frei
Cancer Chemotherapy and Pharmacology|October 29, 2000
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agentsK Lu, C Shih, B A Teicher
The Lancet. Oncology|June 15, 2016
Antibody-drug conjugates for cancer therapyAnish Thomas, Beverly A Teicher, Raffit Hassan
Lung Cancer Management|October 25, 2019
Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?Dmitriy Sonkin, Anish Thomas, Beverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody conjugate therapeutics: challenges and potentialBeverly A Teicher, Ravi V J Chari
Cancer Biochemistry Biophysics|January 29, 1999
Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotypeG Chen, B A Teicher, E Frei
Cancer Genetics|June 23, 2024
Cancer treatments: Past, present, and futureDmitriy Sonkin, Anish Thomas, Beverly A Teicher
Archives of Internal Medicine|December 1, 1978
Minoxidil-induced bullous eruptionT Rosenthal, A Teicher, J Swartz, et al.
Pageof 38